OppenheimerFunds’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$224K Buy
+9,402
New +$214K ﹤0.01% 1672
2018
Q4
Sell
-11,763
Closed -$208K 1817
2018
Q3
$208K Buy
+11,763
New +$229K ﹤0.01% 1772
2018
Q2
Sell
-1,470,543
Closed -$32.6M 1809
2018
Q1
$32.6M Buy
1,470,543
+153,798
+12% +$4.25M 0.04% 426
2017
Q4
$40M Buy
1,316,745
+199,435
+18% +$5.31M 0.05% 372
2017
Q3
$27.1M Buy
1,117,310
+206,743
+23% +$5.5M 0.03% 469
2017
Q2
$22.4M Sell
910,567
-51,345
-5% -$1.09M 0.03% 528
2017
Q1
$20.8M Buy
961,912
+775,049
+415% +$15.8M 0.03% 567
2016
Q4
$2.79M Buy
+186,863
New +$2.7M ﹤0.01% 882

Other funds holding EXEL

OppenheimerFunds's EXEL Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Exelixis (EXEL) in Q1 2019: 9,402 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #1672 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in EXEL as recently as Q3 2018.

OppenheimerFunds first reported a position in EXEL in Q4 2016 and has held it in 8 quarters since. The position peaked at $40M in Q4 2017. 377 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

  • OppenheimerFunds held 9,402 shares of Exelixis worth $224K as of Q1 2019.
  • Exelixis was a new OppenheimerFunds position in Q1 2019.
  • Exelixis made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1672 holding.
  • OppenheimerFunds first reported a position in Exelixis in Q4 2016 and has held it in 8 quarters since.
  • OppenheimerFunds's Exelixis position peaked at $40M in Q4 2017.
  • 377 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.